Trial intelligence / Profile preview

NVC-422 Catheter Irrigation for Urinary Catheter Patency

NCT01243125Phase 2Completed

Sponsor
NovaBay Pharmaceuticals, Inc.
Start
Nov 2010
Primary completion
Jul 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of auriclosene in Urinary Catheter Encrustation, sponsored by NovaBay Pharmaceuticals, Inc.. Started Nov 2010; status: completed.

02

Drugs

auriclosene
03

Conditions

Urinary Catheter Encrustation

Beyond the preview

Go deeper on NCT01243125.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01243125.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call